NYSE:BHCPharmaceuticals
Potential Bausch + Lomb Separation Reframes Bausch Health
Bausch Health Companies, trading at $5.73, has seen pressure on its share price over multiple time frames, with a 20.5% decline year to date and an 83.1% decline over five years. In that context, the continued work on a full split from Bausch + Lomb are central to how investors may reassess the company’s revenue mix and overall structure.